Skip to main content

Duffy Sean P.'s Form 4/A amendment

Amended

Omada Health, Inc. (OMDA) · filed Jul 8, 2026

Accession no.
0001610717-26-000335
Filed
Jul 8, 2026, 8:22 PM ET
Trade date
Jun 24-26, 2026
Filing delay
14 days
Rule 10b5-1 plan
Checked
Original filed
Jun 26, 2026

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $342.1K. It was filed 14 days after the trade.

This amendment replaces 0001610717-26-000299 (filed Jun 26, 2026).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Duffy Sean P.CIK 0002069522Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 24, 2026Common StockMOption exerciseAcquired+2,800$5.82+$16,296414,661Direct
Jun 24, 2026Common StockSSaleDisposed−2,800$19.01F3−$53,238.92411,861Direct
Jun 25, 2026Common StockMOption exerciseAcquired+300$5.82+$1,746412,161Direct
Jun 25, 2026Common StockSSaleDisposed−300$19.00F4−$5,700.99411,861Direct
Jun 26, 2026Common StockMOption exerciseAcquired+9,844$5.82+$57,292.08421,705Direct
Jun 26, 2026Common StockSSaleDisposed−9,844$19.61−$193,013.28411,861Direct
Jun 26, 2026Common StockMOption exerciseAcquired+4,314$8.28+$35,719.92416,175Direct
Jun 26, 2026Common StockSSaleDisposed−4,314$20.90−$90,162.6411,861Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 24, 2026Common StockMOption exerciseDisposed−2,800$0.00$0178,515Direct
Jun 25, 2026Common StockMOption exerciseDisposed−300$0.00$0178,215Direct
Jun 26, 2026Common StockMOption exerciseDisposed−9,844$0.00$0168,371Direct
Jun 26, 2026Common StockMOption exerciseDisposed−4,314$0.00$0129,019Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.

F2

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

F3

This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

F6

100% of the shares subject to the option are fully vested and exercisable

Read the full filing on SEC EDGAR (opens in a new tab)